The U.S. Court of Appeals for the Eleventh Circuit has officially declined to revive a legal challenge concerning a controversial gender-affirming care rule originally introduced by the Biden administration, determining that the litigation has become moot following the administration’s subsequent regulatory updates. The decision, handed down in early September, signals a significant procedural turning point in the ongoing national debate over how the Affordable Care Act’s (ACA) nondiscrimination provisions apply to transgender healthcare.
The appellate panel’s ruling centers on the interpretation of Section 1557 of the ACA, which prohibits discrimination in healthcare programs that receive federal funding. The litigation was initially sparked by a 2021 notification and subsequent guidance from the U.S. Department of Health and Human Services (HHS), which sought to include gender identity under the umbrella of "sex-based discrimination." However, because the Biden administration replaced that guidance with a comprehensive final rule in May 2024, the Eleventh Circuit concluded that the specific legal controversy at hand no longer exists, rendering the appeal a dead letter.
The Evolution of Section 1557: A Decade of Regulatory Volatility
To understand the Eleventh Circuit’s decision, it is necessary to examine the turbulent history of Section 1557, which has been a focal point of partisan and legal conflict for three consecutive presidential administrations. Section 1557 is the first federal civil rights law to prohibit discrimination on the basis of sex in health programs and activities. However, the statute itself does not explicitly define "sex," leaving that task to the executive branch and the courts.
In 2016, the Obama administration issued a final rule stating that the prohibition on sex discrimination included discrimination based on gender identity and termination of pregnancy. This rule was quickly challenged by several states and religious healthcare providers, leading to a nationwide injunction.
In 2020, the Trump administration issued a revised rule that significantly narrowed the scope of Section 1557. This version eliminated the 2016 rule’s definitions of sex discrimination, effectively removing protections for gender identity and abortion access. The Trump-era rule was based on a "plain meaning" interpretation of the word "sex" as being limited to biological sex assigned at birth.
The landscape shifted again in 2021, shortly after President Biden took office. Following the Supreme Court’s landmark decision in Bostock v. Clayton County, which held that sex discrimination in employment includes discrimination based on sexual orientation and gender identity, the Biden administration’s HHS announced it would interpret Section 1557 in a manner consistent with Bostock. This led to the 2021 guidance that prompted the lawsuit eventually dismissed by the Eleventh Circuit.
The Eleventh Circuit Ruling and the Mootness Doctrine
The case before the Eleventh Circuit involved a challenge to the 2021 HHS announcement. The plaintiffs—primarily a coalition of conservative-led states and medical associations—argued that the administration had overstepped its authority by unilaterally redefining "sex" without a formal notice-and-comment rulemaking process. They contended that the interpretation forced doctors to perform procedures, such as gender-reassignment surgeries, that might violate their medical judgment or religious beliefs.
However, while the appeal was pending, HHS finalized a new, more robust regulation in May 2024. This 2024 Final Rule formally codified the inclusion of gender identity protections and established specific compliance requirements for insurers and providers.
In its dismissal, the Eleventh Circuit invoked the "mootness doctrine," a principle derived from Article III of the U.S. Constitution, which limits the jurisdiction of federal courts to actual "cases" and "controversies." If an event occurs during the pendency of an appeal that makes it impossible for the court to grant any effectual relief to the prevailing party, the case must be dismissed as moot.
The court reasoned that because the 2021 guidance had been superseded by the 2024 Final Rule, any ruling on the validity of the 2021 guidance would be merely advisory. The court noted that the plaintiffs’ concerns are now directed toward the 2024 rule, which is already the subject of separate, active litigation in various district courts across the country.
Supporting Data: The Scope of Gender-Affirming Care
The legal battle over Section 1557 carries immense weight due to the scale of the healthcare sector and the population affected. According to data from the Williams Institute at UCLA School of Law, approximately 1.6 million people in the United States identify as transgender, including about 1.3 million adults and 300,000 youth aged 13 to 17.
Access to gender-affirming care—which includes a range of social, psychological, behavioral, and medical interventions—is a critical issue for this demographic. Major medical organizations, including the American Medical Association (AMA), the American Academy of Pediatrics (AAP), and the American Psychological Association (APA), have issued statements supporting the medical necessity of gender-affirming care when administered according to established clinical guidelines.
Furthermore, a 2023 report from the Kaiser Family Foundation (KFF) highlighted that nearly 18% of transgender individuals reported being refused care by a healthcare provider because of their gender identity. The Biden administration has frequently cited these statistics to justify the need for federal protections under Section 1557, arguing that discriminatory practices lead to delayed treatment, poorer health outcomes, and higher rates of suicide and depression among LGBTQ+ individuals.
Chronology of the Legal Conflict
The following timeline illustrates the rapid succession of policy changes and legal maneuvers leading to the Eleventh Circuit’s recent decision:
- June 2020: The Supreme Court decides Bostock v. Clayton County, expanding the definition of sex discrimination under Title VII.
- January 2021: President Biden signs an executive order on preventing and combating discrimination on the basis of gender identity or sexual orientation.
- May 2021: HHS issues a notification stating it will interpret Section 1557’s prohibition on sex discrimination to include gender identity and sexual orientation.
- 2021-2022: Multiple lawsuits are filed by states (including Florida, Texas, and Tennessee) and religious groups to block the 2021 interpretation.
- August 2022: A federal judge in Florida grants a preliminary injunction against the 2021 guidance, leading to the appeal in the Eleventh Circuit.
- May 2024: HHS publishes the 2024 Final Rule on Section 1557, which provides a comprehensive framework for nondiscrimination, explicitly including gender identity.
- July 2024: Federal judges in Mississippi and Texas issue separate stays on the 2024 Final Rule, temporarily blocking its enforcement nationwide or in specific states.
- September 2024: The Eleventh Circuit dismisses the challenge to the 2021 guidance as moot.
Official Responses and Stakeholder Reactions
The Eleventh Circuit’s decision to declare the fight moot has drawn mixed reactions from legal experts and advocacy groups.
Representatives for the Department of Justice, representing HHS, argued that the court’s decision was the only logical outcome. "The 2021 guidance was an interim step," a government spokesperson noted in a related brief. "With the 2024 Final Rule now in place, the previous documents have no legal effect, and the court cannot strike down something that no longer governs."
Conversely, legal counsel for the plaintiffs expressed frustration with the procedural dismissal. Some argued that the administration engaged in "voluntary cessation"—a legal tactic where a defendant stops an allegedly illegal activity just to avoid a court ruling, only to resume it later. However, the Eleventh Circuit rejected this argument, noting that the 2024 Rule was a formal administrative action rather than a temporary pause in enforcement.
Civil rights organizations, such as the Human Rights Campaign (HRC), viewed the dismissal as a neutral procedural step but emphasized that the real battle lies ahead. "While this specific case is over, the fight for the 2024 Final Rule is the new frontline," said an HRC legal analyst. "We are seeing a coordinated effort by several states to strip away these vital healthcare protections."
Broader Impact and Future Implications
While the Eleventh Circuit’s ruling effectively ends one specific lawsuit, it does not resolve the underlying ideological and legal conflict. The focus now shifts entirely to the 2024 Final Rule, which is currently under heavy fire in other jurisdictions.
One of the most significant factors in the future of these cases is the Supreme Court’s recent decision in Loper Bright Enterprises v. Raimondo, which overturned the long-standing "Chevron deference." Under Chevron, courts were generally required to defer to a federal agency’s reasonable interpretation of an ambiguous statute. Without Chevron, judges are now empowered to decide for themselves what Section 1557 means, without giving weight to the HHS interpretation.
This shift in the legal standard makes the 2024 Final Rule particularly vulnerable. If a court decides that the "plain language" of the ACA does not include gender identity, the Biden administration’s rule could be struck down entirely, regardless of the administration’s policy goals.
Furthermore, the "Major Questions Doctrine"—a judicial principle that says agencies need clear congressional authorization for regulations of vast economic and political significance—will likely play a role in future challenges. Opponents of the rule argue that redefining sex discrimination is a "major question" that should be left to Congress, not an executive agency.
As the 2024 Rule makes its way through the courts in Texas, Mississippi, and eventually likely back to the Supreme Court, healthcare providers remain in a state of uncertainty. For now, the Eleventh Circuit has cleared its docket of the old fight, but the broader war over the intersection of civil rights, healthcare, and gender identity is far from over. Providers are advised to monitor the status of the 2024 Rule closely, as its enforcement remains stalled in many parts of the country due to district court injunctions that were not affected by the Eleventh Circuit’s mootness ruling.
